glutamine has been researched along with 3,4-dihydroxyphenylglycol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanaya, S; Komatsu, H; Nemoto, E; Shimauchi, H | 1 |
| Forman, J; Kessing, LV; Knorr, U; Pech, J | 1 |
1 review(s) available for glutamine and 3,4-dihydroxyphenylglycol
| Article | Year |
|---|---|
Poor evidence for putative abnormalities in cerebrospinal fluid neurotransmitters in patients with depression versus healthy non-psychiatric individuals: A systematic review and meta-analyses of 23 studies.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Depressive Disorder, Major; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Young Adult | 2018 |
1 other study(ies) available for glutamine and 3,4-dihydroxyphenylglycol
| Article | Year |
|---|---|
Metabotropic glutamate receptor 1 promotes cementoblast proliferation via MAP kinase signaling pathways.
Topics: Animals; Cell Line; Cell Nucleus; Cell Proliferation; Cyclin D1; Dental Cementum; Glutamine; MAP Kinase Signaling System; Methoxyhydroxyphenylglycol; Mice; Minor Histocompatibility Antigens; Phosphorylation; Protein Kinase Inhibitors; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Receptors, Metabotropic Glutamate | 2016 |